Squarepoint’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.41M Sell
107,500
-12,900
-11% -$1.04M 0.01% 1221
2026
Q1
$10.4M Buy
120,400
+87,700
+268% +$8.4M 0.01% 1045
2025
Q4
$3.14M Buy
32,700
+22,000
+206% +$2.14M ﹤0.01% 1770
2025
Q3
$1.02M Sell
10,700
-500
-4% -$46K ﹤0.01% 2676
2025
Q2
$976K Sell
11,200
-1,100
-9% -$93.3K ﹤0.01% 2682
2025
Q1
$1.11M Sell
12,300
-72,400
-85% -$6.48M ﹤0.01% 2577
2024
Q4
$6.77M Sell
84,700
-9,400
-10% -$814K 0.01% 1410
2024
Q3
$8.47M Buy
94,100
+84,700
+901% +$7.13M 0.01% 1051
2024
Q2
$740K Sell
9,400
-29,200
-76% -$2.39M ﹤0.01% 2788
2024
Q1
$3.36M Buy
38,600
+26,600
+222% +$2.27M 0.01% 1744
2023
Q4
$989K Buy
+12,000
New +$915K ﹤0.01% 2534
2023
Q3
Sell
-5,300
Closed -$467K 4062
2023
Q2
$467K Sell
5,300
-27,300
-84% -$2.35M ﹤0.01% 2660
2023
Q1
$2.63M Buy
+32,600
New +$2.66M 0.01% 1259
2022
Q3
Sell
-2,700
Closed -$242K 3243
2022
Q2
$242K Sell
2,700
-115,600
-98% -$11.7M ﹤0.01% 2377
2022
Q1
$13.1M Buy
+118,300
New +$12.5M 0.06% 363
2021
Q4
Sell
-6,100
Closed -$765K 3392
2021
Q3
$765K Buy
6,100
+1,900
+45% +$246K ﹤0.01% 1720
2021
Q2
$521K Buy
+4,200
New +$527K ﹤0.01% 2097
2021
Q1
Sell
-14,800
Closed -$1.73M 3414
2020
Q4
$1.73M Buy
+14,800
New +$1.63M 0.01% 1012

Other funds holding MDT

Squarepoint's MDT Position: Q2 2026 in Review

Squarepoint increased its Medtronic (MDT) stake by 29% in Q2 2026, buying an estimated $39M and bringing the position to 2,166,735 shares worth $170M. The position accounts for 0.19% of the portfolio, ranked #88.

Squarepoint first reported a position in MDT in Q1 2015 and has held it in 42 quarters since. 2,134 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Squarepoint held 2,166,735 shares of Medtronic worth $170M as of Q2 2026.
  • Squarepoint bought 483,231 Medtronic shares in Q2 2026, an estimated $39M.
  • Medtronic made up 0.19% of Squarepoint's portfolio in Q2 2026, its #88 holding.
  • Squarepoint first reported a position in Medtronic in Q1 2015 and has held it in 42 quarters since.
  • 2,134 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Squarepoint's 13F filing for Q2 2026, filed 14 Aug 2026.